Spermidine is a small-molecule polyamine studied in aging research, especially for autophagy, cognition, immune aging, and metabolic biomarkers. Human randomized trials exist, but results vary by dose, population, and product. It should not be treated as a proven longevity therapy, and Chia does not currently offer spermidine.
Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →What it is
Spermidine is a small molecule in the polyamine family. Polyamines are compounds involved in cell growth, stress responses, and normal cellular maintenance; spermidine has been studied in human trials for healthy-aging biomarkers, cognition, immune aging, dental uses, and other early research areas 1 4 7 12.
In practical terms, most people encounter spermidine as a dietary supplement or as part of a combination product. In research, it has appeared as spermidine supplementation, spermidine-rich rice germ extract, fasting-mimetic combinations, and local dental gel or adjunctive delivery 2 3 7 12.
At Chia, we treat metabolic health and healthy-aging questions every day, but spermidine is not in our current treatment catalog. If you are comparing healthy-aging topics, our educational pages on metformin, rapamycin, and glutathione may help you separate evidence strength from online hype.
Mechanism of action
Spermidine’s human mechanism is still not fully established. The main proposed pathway is support of cellular housekeeping, including autophagy, but human studies usually measure biomarkers rather than directly proving that spermidine improves long-term health through autophagy 12.
Polyamines and cellular housekeeping
Polyamines are small charged molecules found in cells. Human trials have studied circulating polyamines, mitochondrial-related measures, immune cell senescence, oxidative stress biomarkers, inflammatory biomarkers, and cardioprotective biomarkers, but these are indirect readouts rather than proof of a clinical outcome 2 3 4 5.
Autophagy research: what human studies can and cannot show
Autophagy means the cell’s cleanup and recycling process. A proof-of-concept pilot study evaluated a spermidine-rich rice germ extract supplement for biomarkers of healthy aging and autophagy, which supports interest in the pathway but does not prove longer human life or broad disease risk reduction 12.
Evidence
Spermidine has an assigned evidence grade of A — two or more human randomised controlled trials. That is a statement about the amount and design of published evidence, not a claim that spermidine works, is safe, or improves lifespan 1 2 4.
Cognition and subjective cognitive decline
A randomized clinical trial studied spermidine supplementation in older adults with subjective cognitive decline, looking at cognition and biomarkers 1. An earlier study also evaluated safety and tolerability of spermidine supplementation in older adults with subjective cognitive decline, so cognition is a real research area, but not a settled clinical use 9.
Dementia-related pilot data
A 3-month trial reported early results in older adults suffering from dementia 6. Because this was an early trial, it should be read as preliminary dementia-related research, not proof that spermidine improves dementia symptoms or changes the course of disease.
Immune aging and vaccine-response pilot data
A pilot study in healthy older adults evaluated spermidine in relation to immune cell senescence and vaccine responses 4. This supports careful discussion of immune-aging research, but pilot data should not be stretched into claims that spermidine protects people from infection or reliably improves vaccine outcomes.
Circulating polyamines and biomarker findings
In an exploratory double-blind randomized trial in older men, spermidine supplementation at 40 mg/day had minimal effects on circulating polyamines 2. That finding matters because it shows that taking more of a compound does not always translate into a clear blood-level change.
A randomized phase 2 trial of lubiprostone in chronic kidney disease reported insights into mitochondrial function and polyamines 5. Because that study focused on lubiprostone and chronic kidney disease, it should not be used as proof that spermidine supplements improve kidney function.
Oral and dental studies using local spermidine delivery
Dental research is a separate evidence lane. A double-blind randomized clinical trial studied spermidine and calcium chloride as a local adjunct to non-surgical mechanical debridement for peri-implant mucositis 7. Local dental delivery should not be treated as evidence for oral supplement benefits.
Hair, skin, and other early research areas
Hair and skin research is early and mixed in what it can tell us. One study described a multi-targeting hair growth strategy with in vitro and in vivo components 10. A phase 3 skin cancer prevention study involved alpha-difluoromethylornithine, a polyamine-pathway compound, in people with prior skin cancer, but that is not the same as testing spermidine as a skin supplement 11.
Some healthy-aging studies use combination products. A pilot dose-escalation study tested a fasting-mimetic product containing spermidine, nicotinamide, palmitoylethanolamide, and oleoylethanolamide; any effects from that product cannot be credited to spermidine alone 3.
What studies exist
| Year | Design | Study | Journal | Record |
|---|---|---|---|---|
| 2022 | Randomised controlled trial | Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial | JAMA network open | PMID 35616942 |
| 2024 | Randomised controlled trial | Supplementation of spermidine at 40 mg/day has minimal effects on circulating polyamines: An exploratory double-blind randomized controlled trial in older men | Nutrition research (New York, N.Y.) | PMID 39405978 |
| 2024 | Randomised controlled trial | Absorption, anti-inflammatory, antioxidant, and cardioprotective impacts of a novel fasting mimetic containing spermidine, nicotinamide, palmitoylethanolamide, and oleoylethanolami | Nutrition research (New York, N.Y.) | PMID 39549554 |
| 2025 | Randomised controlled trial | Effects of Spermidine-Rich Rice Germ Extract Supplement on Biomarkers of Healthy Aging and Autophagy-Proof-of-Concept Pilot Study | Alternative therapies in health and medicine | PMID 40862848 |
| 2026 | Randomised controlled trial | Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study | Aging cell | PMID 42169618 |
| 2025 | Randomised controlled trial | Lubiprostone in chronic kidney disease: Insights into mitochondrial function and polyamines from a randomized phase 2 clinical trial | Science advances | PMID 40880481 |
| 2021 | Randomised controlled trial | The positive effect of spermidine in older adults suffering from dementia : First results of a 3-month trial | Wiener klinische Wochenschrift | PMID 33211152 |
| 2024 | Randomised controlled trial | Treatment of peri-implant mucositis using spermidine and calcium chloride as local adjunctive delivery to non-surgical mechanical debridement: a double-blind randomized controlled | Clinical oral investigations | PMID 39304548 |
| 2018 | Randomised controlled trial | A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression | PloS one | PMID 29870556 |
| 2018 | Randomised controlled trial | Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline | Aging | PMID 29315079 |
| 2018 | Randomised controlled trial | New multi-targeting strategy in hair growth promotion: in vitro and in vivo studies | Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia | PMID 29766701 |
| 2010 | Randomised controlled trial | A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer | Cancer prevention research (Philadelphia, Pa.) | PMID 20051371 |
| Registration | Phase | Status | Enrolment | Title |
|---|---|---|---|---|
| NCT07058974 | PHASE1 | ACTIVE_NOT_RECRUITING | 20 | A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation |
| NCT07383311 | NA | RECRUITING | 76 | Autophagy-Enhancers to Reduce Sleep Disturbances |
| NCT06186102 | PHASE2 | COMPLETED | 187 | Polyamine Treatment in Elderly Patients With Coronary Artery Disease |
| NCT05128331 | NA | UNKNOWN | 30 | sPERMIdine supplemenTation on Metabolic, Neuronal and Cardiovascular Response to Exercise TRAINING |
| NCT05926557 | NA | COMPLETED | 20 | Treatment of Peri-implant Mucositis by Application of a Spermidine-based Gel |
| NCT07675200 | NA | RECRUITING | 70 | Effects of Miricell Supplementation on Biomarkers of Healthy Aging and Autophagy |
| NCT04823806 | NA | UNKNOWN | 80 | An Exploratory Clinical Study on Autophagy and Multi-level Molecular Profiling During Spermidine Supplementation |
| NCT03378843 | N/A | COMPLETED | 829 | Spermidine Intake and All-cause Mortality |
This table is retrieved from PubMed and ClinicalTrials.gov rather than assembled by hand, so it shows what is indexed — including the absences. Last retrieved 2026-09-11.
Reported dosing ranges
Spermidine dosing in this evidence set is best described as “what studies used,” not what a person should take. Published trials vary by product type, population, and endpoint, and online dosing calculators cannot replace clinical review 2 3 7 12.
| Study or source | Population or setting | Reported studied exposure | What this can and cannot tell us |
|---|---|---|---|
| Keohane et al., 2024 | Older men | Spermidine supplementation at 40 mg/day | Reported minimal effects on circulating polyamines; this does not establish an ideal dose for patients 2. |
| Pekar et al., 2021 | Older adults suffering from dementia | A 3-month trial of spermidine | Shows short-term dementia-related research exists; it does not prove long-term benefit or define routine use 6. |
| Rhodes et al., 2024 | Healthy young adult men | Pilot dose-escalation study of a fasting-mimetic combination containing spermidine, nicotinamide, palmitoylethanolamide, and oleoylethanolamide | Combination-product findings cannot be attributed to spermidine alone 3. |
| Bruno et al., 2025 | Healthy-aging and autophagy biomarker study | Spermidine-rich rice germ extract supplement | Supports biomarker research, not a lifespan-extension claim 12. |
| Iorio-Siciliano et al., 2024 | Peri-implant mucositis | Local adjunctive delivery with spermidine and calcium chloride | Local dental delivery is different from oral supplementation 7. |
Why online dosing calculators cannot replace clinical review
A dose used in a trial is not a personal dosing plan. A clinician can review age, pregnancy plans, cancer history, immune status, kidney disease, prescriptions, supplement stack, and the exact product label before weighing risks and uncertainties.
Legal status
Our regulatory log holds no confirmed federal action for Spermidine. That means we have not found one with a primary source — not that none exists.
This section is generated from a dated log of federal actions rather than written by hand, and it is re-checked daily against the Federal Register and FDA sources. Last checked 2026-09-11. See the full legal-status tracker for every compound we follow.
Safety
Spermidine safety data in humans exists, but it is not the same as broad long-term reassurance. A study in older adults with subjective cognitive decline evaluated safety and tolerability, while other trials studied specific populations and products over defined time frames 9 1 2.
Tolerability findings in older-adult trials
The older-adult safety and tolerability study is useful because it directly studied spermidine supplementation in a human population of interest 9. Still, it does not answer every safety question for younger adults, pregnancy, cancer treatment, immune suppression, chronic kidney disease, or long-term use.
Why supplement purity and formulation matter
Trial products are not always the same as commercial products. Some studies used spermidine-rich rice germ extract, some used local dental delivery, and some used combination formulas with nicotinamide, palmitoylethanolamide, and oleoylethanolamide 3 7 12.
That difference matters because dose, purity, ingredients, and quality controls can change what a person is exposed to. “Research use only” material is not made for people and should not be treated like a clinician-reviewed medication or a quality-controlled supplement.
When to stop and ask a clinician
Stop using a product and ask a clinician if you develop concerning symptoms, have an allergic-type reaction, start a new prescription, become pregnant, begin cancer treatment, or are advised to avoid supplements before a procedure. No trial in this evidence set proves that spermidine is safe for every person or every combination.
Interactions
Spermidine interaction studies are limited in this evidence set. The available randomized trials focus on specific endpoints such as cognition, circulating polyamines, immune measures, dental therapy, and biomarkers, not a complete drug-interaction map 1 2 4 7.
Older adults, cognitive symptoms, cancer history, pregnancy, and chronic illness
People with cognitive symptoms should not use a supplement as a substitute for a medical evaluation. The cognition and dementia studies show research interest, but they do not replace diagnosis, medication review, or evaluation for reversible causes of cognitive change 1 6.
People with a cancer history or active cancer treatment should be especially careful. A skin cancer prevention trial in the polyamine pathway studied alpha-difluoromethylornithine in people with prior skin cancer, which shows the pathway has been studied in oncology-adjacent settings but does not establish safety for spermidine supplement use during cancer care 11.
Combining spermidine with other supplements or medications
Combination products create attribution and safety problems. In the fasting-mimetic pilot study, spermidine was combined with nicotinamide, palmitoylethanolamide, and oleoylethanolamide, so benefits or side effects cannot be assigned to one ingredient with confidence 3.
If you are comparing spermidine with other metabolic or healthy-aging topics, it helps to review each one separately. Our Chia articles on metformin, rapamycin, and glutathione explain different evidence bases and safety questions.
How to obtain it legally
Spermidine access should start with clinical judgment, not an online dosing chart. A clinician can review why you are interested, what product you are considering, your medical history, your medication list, and whether the evidence matches your goal.
What a clinician can help review
- Whether your goal is cognition, immune aging, dental health, metabolic biomarkers, or general healthy aging.
- Whether the evidence you are relying on used oral supplementation, a spermidine-rich extract, a combination product, or local dental delivery 2 3 7 12.
- Whether pregnancy, cancer care, immune suppression, kidney disease, cognitive symptoms, or prescription medications change the risk-benefit discussion.
- Whether the product label, ingredient list, and testing standards are clear enough to review.
What a research-chemical vendor is not
A research-chemical vendor is not a medical evaluation, not a prescription, and not a licensed pharmacy relationship. Products sold for research use may raise identity, impurity, sterility, and handling concerns, and they are not designed as patient care.
Chia’s role: education-only for spermidine
Chia does not currently offer spermidine. When Chia does prescribe treatments we offer, the process is 100% online: a short health questionnaire, review by a licensed US provider, prescribing only when clinically appropriate, and home delivery from state-licensed US 503A compounding pharmacies. A prescription is never guaranteed, and compounded drugs are not FDA-approved.
How does spermidine compare with other healthy-aging topics?
Spermidine sits in the healthy-aging conversation because of polyamines, autophagy, cognition, immune aging, and biomarkers. It should be compared by evidence type, endpoint, and safety limits—not by social-media claims.
| Topic | Main research frame | What to keep in mind |
|---|---|---|
| Spermidine | Polyamines, autophagy-related biomarkers, cognition, immune aging, dental delivery, and combination products 1 3 4 7 12 | Human randomized trials exist, but they do not prove lifespan extension. |
| NAD+ discussions | Cell-energy and redox biology are common themes in healthy-aging conversations. | Compare product type and evidence carefully; Chia offers NAD+ injections and nasal spray, but this spermidine page is education-only. |
| Metformin | Metabolic health and aging biology discussions. | Read our metformin evidence guide for a separate risk-benefit discussion. |
| Rapamycin | mTOR pathway and longevity research discussions. | Read our rapamycin evidence guide for a separate discussion of evidence and safety. |
| Glutathione | Oxidative stress and antioxidant systems. | Read our glutathione guide for a different mechanism and access discussion. |
Spermidine is a polyamine involved in normal cell biology. In human research, it has been studied for cognition, immune-aging measures, circulating polyamines, autophagy-related biomarkers, and local dental uses. It is not proven to extend human lifespan.
Autophagy is the main proposed healthy-aging pathway for spermidine, but human studies usually measure biomarkers rather than directly proving that spermidine improves long-term health through autophagy.
One double-blind randomized trial in older men studied spermidine at 40 mg/day and reported minimal effects on circulating polyamines. Other studies used different products, extracts, combinations, or local dental delivery, so trial doses should not be treated as personal dosing instructions.
Possible downsides include uncertain long-term safety, product-quality differences, unclear interactions, and the risk of using a supplement when symptoms need medical evaluation. People who are pregnant, trying to conceive, immunocompromised, being treated for cancer, older, chronically ill, or taking prescriptions should discuss it with a clinician.
There is no single proven best form based on the evidence in this article. Studies have used spermidine supplementation, spermidine-rich rice germ extract, combination products, and local dental delivery, and those findings are not interchangeable.
No. Human trials have studied biomarkers, cognition, immune measures, and specific clinical settings, but this evidence does not prove that spermidine extends human lifespan.
Food content questions need food-composition data, which is not part of the evidence set used for this article. If you want to change your diet for spermidine intake, a clinician or dietitian can help review the safest approach for your health history.
No. Chia does not currently offer spermidine. This page is education-only and should not be read as an offer of treatment, prescribing, or individualized supplement guidance.
References
- 1.PMID 35616942 [randomised controlled trial] Schwarz C, Benson GS, Horn N, et al. Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial. JAMA network open. 2022.
- 2.PMID 39405978 [randomised controlled trial] Keohane P, Everett JR, Pereira R, et al. Supplementation of spermidine at 40 mg/day has minimal effects on circulating polyamines: An exploratory double-blind randomized controlled trial in older men. Nutrition research (New York, N.Y.). 2024.
- 3.PMID 39549554 [randomised controlled trial] Rhodes CH, Hong BV, Tang X, et al. Absorption, anti-inflammatory, antioxidant, and cardioprotective impacts of a novel fasting mimetic containing spermidine, nicotinamide, palmitoylethanolamide, and oleoylethanolamide: A pilot dose-escalation study in healthy young adult men. Nutrition research (New York, N.Y.). 2024.
- 4.PMID 42169618 [randomised controlled trial] Alsaleh G, Ali M, Kayvanjoo AH, et al. Spermidine Mitigates Immune Cell Senescence and Boosts Vaccine Responses in Healthy Older Adults-A Pilot Study. Aging cell. 2026.
- 5.PMID 40880481 [randomised controlled trial] Watanabe S, Nakayama M, Yokoo T, et al. Lubiprostone in chronic kidney disease: Insights into mitochondrial function and polyamines from a randomized phase 2 clinical trial. Science advances. 2025.
- 6.PMID 33211152 [randomised controlled trial] Pekar T, Bruckner K, Pauschenwein-Frantsich S, et al. The positive effect of spermidine in older adults suffering from dementia : First results of a 3-month trial. Wiener klinische Wochenschrift. 2021.
- 7.PMID 39304548 [randomised controlled trial] Iorio-Siciliano V, Marasca D, Mauriello L, et al. Treatment of peri-implant mucositis using spermidine and calcium chloride as local adjunctive delivery to non-surgical mechanical debridement: a double-blind randomized controlled clinical trial. Clinical oral investigations. 2024.
- 8.PMID 29870556 [randomised controlled trial] Blasco H, Patin F, Descat A, et al. A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression. PloS one. 2018.
- 9.PMID 29315079 [randomised controlled trial] Schwarz C, Stekovic S, Wirth M, et al. Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline. Aging. 2018.
- 10.PMID 29766701 [randomised controlled trial] Marzani B, Pinto D, Sorbellini E, et al. New multi-targeting strategy in hair growth promotion: in vitro and in vivo studies. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 2018.
- 11.PMID 20051371 [randomised controlled trial] Bailey HH, Kim K, Verma AK, et al. A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer. Cancer prevention research (Philadelphia, Pa.). 2010.
- 12.PMID 40862848 [randomised controlled trial] Bruno G, La Monica M, Ziegenfuss TN. Effects of Spermidine-Rich Rice Germ Extract Supplement on Biomarkers of Healthy Aging and Autophagy-Proof-of-Concept Pilot Study. Alternative therapies in health and medicine. 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



